The COVID-19 Antigen Rapid Test is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab, nasal swab or oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider.
Nasopharyngeal Swab, Nasal Swab, Oropharyngeal Swab
| Catalog No. | Specifications | Reaction Time | Sensitivity | Specificity | Storage Condition | Shelf Life | Certification |
|---|---|---|---|---|---|---|---|
| ICOV5002-B001 | 1 test/box | 15 mins | For nasopharyngeal swab: 96.0% (95% CI: 93.0%-97.8%) For nasal swab: 95.5% (95% CI: 89.8%-98.0%) | For nasopharyngeal swab: 100% (95% CI: 99.6%-100%) For nasal swab: 100% (95% CI: 99.2%-100%) | 4-30℃ | 24 months | CE |
| ICOV5002-B005 | 5 tests/box | ||||||
| ICOV5002-B025 | 25 tests/box |
These products can not be sold in the United States.
